The issue for this committee is how the FDA seeks to regulate in this space and what that means to patients and innovators both now and in the future.
Fred Upton: “The issue for this committee is how the FDA seeks to regulate in this space and what that means to patients and…”
Editor's note · Context
Upton discusses the implications of FDA regulation on patients and innovators.
Share
More from Fred Upton
This bill, ARPA-H, can provide the breakthroughs necessary to find cures for those diseases. The President has already signed $1 billion for this program into law. So what we need now is bipartisan authorization to complete the work. This…
The first would be expanding energy production in the United States. So, of course, one way to do that is through oil and gas, but other ways is through renewable energy.
This is -- I think, that call -- I think he might have been from South Carolina.
The Strategic Petroleum Reserve was created by Congress to respond to several oil supply disruptions, not as a bailout. This administration has to end its hostility to producing energy right here under our feet and reverse the policies…





